TP53 and neoplasm: There was no difference in relation to age, size of the residual disease, tumor grade, platinum sensitivity, TP53 accumulation, chemotherapy response, growth type, mitotic activity, inflammatory cells infiltration, and necrosis (Supplementary Table S2).